Ciaraldi T P, Horuk R, Matthaei S
Biochem J. 1986 Nov 15;240(1):115-23. doi: 10.1042/bj2400115.
The properties of the glucose-transport systems in rat adipocytes and hepatocytes were compared in cells prepared from the same animals. Hormones and other agents which cause a large stimulation of 3-O-methylglucose transport in adipocytes were without acute effect in hepatocytes. Hepatocytes displayed a lower affinity for 3-O-methylglucose (20 mM) and alternative substrates than adipocytes (6 mM), whereas inhibitor affinities were similar in both cell types. The concentration and distribution of glucose transporters were determined by Scatchard analysis of D-glucose-inhibitable [3H]cytochalasin B binding to subcellular fractions. In liver, most of the transporters were located in the plasma membrane (42 +/- 5 pmol/mg of protein) with a small amount (4 +/- 3 pmol/mg) in the low-density microsomal fraction ('microsomes'), the reverse of the situation in adipocytes. Glucose transporters were covalently labelled with [3H]cytochalasin B by using the photochemical cross-linking agent hydroxysuccinimidyl-4-azidobenzoate and analysed by SDS/polyacrylamide-gel electrophoresis. A single D-glucose-inhibitable peak with a molecular mass of 40-50 kDa was seen in both plasma membrane and low-density microsomes. This peak was further characterized by isoelectric focusing and revealed a single peak of specific [3H]cytochalasin B binding at pI 6.05 in both low-density microsomes and plasma membrane, compared with peaks at pI 6.4 and 5.6 in adipocyte membranes. In summary: the glucose-transport system in hepatocytes has a lower affinity and higher capacity than that in adipocytes, and is also not accurately modulated by insulin; the subcellular distribution of glucose transporters in the liver suggests that few intracellular transporters would be available for translocation; the liver transporter has a molecular mass similar to that of the adipocyte transporter; the liver glucose transporter exists as a single charged form (pI 6.05), compared with the multiple forms in adipocytes. This difference in charge could reflect a functionally important difference in molecular structure between the two cell types.
在取自同一动物的细胞中,对大鼠脂肪细胞和肝细胞中葡萄糖转运系统的特性进行了比较。在脂肪细胞中能大幅刺激3 - O - 甲基葡萄糖转运的激素和其他因子,对肝细胞没有急性作用。肝细胞对3 - O - 甲基葡萄糖(20 mM)和其他替代底物的亲和力低于脂肪细胞(6 mM),而两种细胞类型中抑制剂的亲和力相似。通过对D - 葡萄糖抑制的[³H]细胞松弛素B与亚细胞组分结合进行Scatchard分析,确定了葡萄糖转运蛋白的浓度和分布。在肝脏中,大多数转运蛋白位于质膜(42±5 pmol/mg蛋白质),在低密度微粒体部分(“微粒体”)中有少量(4±3 pmol/mg),这与脂肪细胞中的情况相反。通过使用光化学交联剂羟基琥珀酰亚胺 - 4 - 叠氮苯甲酸,用[³H]细胞松弛素B对葡萄糖转运蛋白进行共价标记,并通过SDS/聚丙烯酰胺凝胶电泳进行分析。在质膜和低密度微粒体中均可见一个分子量为40 - 50 kDa的单一D - 葡萄糖抑制峰。通过等电聚焦对该峰进行进一步表征,结果显示在低密度微粒体和质膜中,特异性[³H]细胞松弛素B结合的单一峰在pI 6.05处,而脂肪细胞膜中的峰在pI 6.4和5.6处。总之:肝细胞中的葡萄糖转运系统比脂肪细胞中的亲和力更低、容量更高,并且也不受胰岛素的精确调节;肝脏中葡萄糖转运蛋白的亚细胞分布表明,几乎没有细胞内转运蛋白可用于转位;肝脏转运蛋白的分子量与脂肪细胞转运蛋白的相似;与脂肪细胞中的多种形式相比,肝脏葡萄糖转运蛋白以单一电荷形式(pI 6.05)存在。这种电荷差异可能反映了两种细胞类型在分子结构上功能上的重要差异。